Drug
Eratrectinib clinical trials
Keep track of what changes. Save the eratrectinib studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Development codes
Combined with it in one product
Studies by the year they started
6 studies that test it; most in 2024 (2)
| Year | Studies |
|---|---|
| 2020 | 1 |
| 2022 | 1 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses eratrectinib is read from its arms, and is right about nine times in ten.
Testing it · 6
- A Phase Ib, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of VC004 Capsules for Pain in Bone MetastasesNot yet recruitingPhase 1Jiangsu vcare pharmaceutical technology co., LTDNCT07731685Written as VC004 low dose
- Phase III Clinical Study of VC004 in Patients With Localized Advanced/ Metastatic Solid TumorsRecruitingPhase 3Jiangsu vcare pharmaceutical technology co., LTDNCT06658353Written as VC004 Capsules
- A Clinical Trial to Evaluate the Effects of Itraconazole or Rifampicin on the Pharmacokinetics of VC004 Capsules in Healthy Adult SubjectsCompletedPhase 1Jiangsu vcare pharmaceutical technology co., LTDNCT06619951Written as VC004 and Itraconazole
- Food Effect and Relative Bioavailability Study of VC004 Capsules in Healthy Adult SubjectsCompletedPhase 1Jiangsu vcare pharmaceutical technology co., LTDNCT06529445Written as High Dose VC004 Capsules
- The Phase I/Phase II Clinical Study of VC004 in Patients With Localized Advanced/Metastatic Solid TumorsStatus unknownPhase 1/2Jiangsu vcare pharmaceutical technology co., LTDNCT04614740Written as VC004
- Food Effect Study on the Pharmacokinetics of VC004 Capsules in Healthy Adult SubjectsCompletedPhase 1Jiangsu vcare pharmaceutical technology co., LTDNCT05528120Written as VC004 Capsules
Codes
What other systems call eratrectinib · ClinicalTrials.gg INT018155
- UNII (FDA) UP4C2TYD49ERATRECTINIBConfirmed FDA, Wikidata
- Wikidata Q140529164eratrectinibConfirmed FDA, Wikidata
- NCI Thesaurus C178578EratrectinibOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | UP4C2TYD49 | ERATRECTINIB | Confirmed FDA, Wikidata |
| Wikidata | Q140529164 | eratrectinib | Confirmed FDA, Wikidata |
| NCI Thesaurus | C178578 | Eratrectinib | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.